Once again they missed the memo that WHO reclassified stroke in 2006, now a neurological disease not cardiovascular disease?
If our researchers are out-of-date how do you think your stroke doctors are keeping up? Does your stroke hospital have a research analysis employee whose only job is to take stroke research and implement into interventions and train the staff in the latest? If not you don't have a stroke hospital.
The MACE definition is wrong.
Relation between improvement of glycemic control and reduction of major cardiovascular events in 15 cardiovascular outcome trials: a meta‐analysis with metaregression
Diabetes, Obesity and Metabolism — Giugliano D, Bellastella G, Longo M, et al. | April 08, 2020
lowering the risk of nonfatal stroke, at least during treatment
with GLP‐1 RAs, without influencing the other two components of MACE.
A meta‐analysis with metaregression was conducted to disclose associations between reduction of HbA1c
levels and risk of major cardiovascular events (MACE) in all
cardiovascular outcome trials (CVOTs) so far published in patients with
type 2 diabetes (T2D). Researchers carried out an electronic search up
to February 10, 2020 to ascertain eligible trials. They evaluated pooled
summary estimates and 95% confidence intervals according to random
effects model applying the Paule‐Mandel method; restricted maximum
likelihood estimators were applied to calculate model parameters in the
metaregression. This study included 15 CVOTs involving a total of
138,250 patients. In CVOTs, the blood glucose reduction may play some
role in
Read the full article on Diabetes, Obesity and Metabolism
No comments:
Post a Comment